News & Publications

News and Research

Local Governments Offer to Subsidize Infertility Teatment for Men

Headlines in Reproductive Medicine September 29, 2014

To counter the nation’s ultralow birthrate, five prefectural governments are offering to subsidize fertility treatment for men, sources said, in addition to the nationwide program.

Pediatrics Group Says IUDs Teens’ Best Birth Control Choice

Headlines in Reproductive Medicine September 29, 2014

Pediatricians, take note: From now on, IUDs are the first-line choice for adolescents seeking long-term contraception.

French Researchers 3D Print Embryo Models for In Vitro Fertilization

Headlines in Reproductive Medicine September 29, 2014

Clearly, anything that can be done to improve the chance of successful fertilization followed by a healthy pregnancy and baby is extremely valuable. It is here that 3D printing enters the story.

Items of Interest from the FDA

ASRM Bulletins September 26, 2014

The Food and Drug Administration (FDA) has issued a revised draft guidance for industry entitled “Draft Guidance on Estradiol.” The guidance provides specific recommendations on the design of bioequivalence studies to support abbreviated new drug applications (ANDAs) for estradiol vaginal cream.

Highlights from Fertility and Sterility: New Global Standardized Tools for Endometriosis Research

Press Releases September 26, 2014

Today, in Fertility and Sterility, the World Endometriosis Research Foundation (WERF) has published a suite of four articles that constitute a standardized approach for researchers to use in their investigations of the disease, in its many subtypes and manifestations.  Fertility and Sterility, the journal of the American Society for Reproductive Medicine (ASRM), will make the articles freely accessible for the greater benefit of the endometriosis research community.

ASRM and SART Comment on Proposed Changes to National ART Surveillance System

ASRM Bulletins September 26, 2014

This week, ASRM and SART submitted comments to the Centers for Disease Control and Prevention on proposed changes to the National ART Surveillance System data reporting requirements. The Fertility Clinic Success Rate and Certification Act of 1992 requires specific data related to pregnancy and live births achieved using ART, as well as clinic specific live birth rates, be reported to the CDC on an annual basis by clinics at which assisted reproductive technology procedures are performed.

Diet Affects Sperm Competitiveness

Headlines in Reproductive Medicine September 26, 2014

It's well known that omega-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA) can help to prevent heart disease but new research has found that these essential fatty acids can also increase the chance of paternity success.

CVS Cuts Checks After Charging Women Birth Control Co-Pay

Headlines in Reproductive Medicine September 26, 2014

One of the largest U.S. pharmacy chains is reimbursing women it illegally charged co-pays for birth control, a practice that is no longer legal under ObamaCare.

Emergency Contraception May Not Be Available to All Young Men

Headlines in Reproductive Medicine September 26, 2014

Young men often run into difficulties when they attempt to buy the morning-after pill for their partners, a new study suggests.

Praying for a Child: The Catholic Church Makes Life Impossible for Infertile Women

Headlines in Reproductive Medicine September 25, 2014

The Catholic Church’s rigid stance against abortion and contraception is well known. In Humanae Vitae, Pope Paul VI described the “transmission of human life” as a “sacred duty.” In Catholic thought, it is incumbent upon us to create life, not to prevent or destroy it. What is less well known is that this same logic is arrayed against women who seek to become pregnant through certain reproductive technologies such as IVF, in which a significant number of embryos are fertilized, many of which are then typically destroyed. Embryo destruction in the course of fertility treatments is, like abortion, murder in the eyes of the church.


View Details
Learn More | Join | Renew
Back to Top